Market LIVE
Published markets; coverage varies by country
Product profile · United States

BEXLUTRY

 ·  Patent Litigation & Settlement History ↓

IngredientLUTETIUM LU-177 DOTATATE
Application typeNDA
Application218525
Product001
Dosage formSOLUTION
RouteINTRAVENOUS
Strength10mCi/ML
Approval date2026-09-14
Marketing statusPrescription
Status event—
ApplicantCURIUM
Product source

Current GenericRadar decision

Year2026
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typeAPPROVAL_YEAR_FALLBACK
Anchor date2026-09-14
Patent anchor—
Exclusivity anchor—
Protection date—
First Final ANDA—
Status event—

GNR judgment: DEEP_REVIEW. Reference year: 2026. Anchor type: APPROVAL_YEAR_FALLBACK. Patent anchor: not recorded. Exclusivity anchor: not recorded. Anchor date: 2026-09-14. Patent tail: no. Exclusivity tail: no. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
No patent facts are recorded for this product.

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
No exclusivity facts are recorded in this product snapshot.

2026-10-12 · SOURCE_PUBLICATION_LAG · Historical coverage: ANNUALS_2011_2026_REVIEWED

2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
217060 / 001APPLICATION_FINAL_OBSERVATION · FINAL_PRODUCT_DATE_UNVERIFIED——LANTHEUS MEDICALNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
217060 / 001FINAL_APPROVAL · FINAL_APPROVED2026-09-21—LANTHEUS MEDICALNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 1 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
217060 / 001LANTHEUS MEDICALFINAL_APPROVAL · FINAL_APPROVED2026-09-21 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
Decision evidence (1)
TypeDateRoleBasisSource
REGULATORY_STATUS2026-09-14DECISION_BASISNo qualifying TRUE_DS/DS-equivalent or historical full-scope regulatory anchor established. Apply APPROVAL_YEAR_FALLBACK and retain all formulation/use FTO facts. Current own-right inventory is not certified because the FDA download predates approval. Do not infer no rights or copy LUTATHERA rights.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.